SMTL ID : 2qme.2 (1 other biounit)

Crystal structure of human RAC3 in complex with CRIB domain of human p21-activated kinase 1 (PAK1)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.75 Å

Oligo State

hetero-2-2-mer

Ligands

2 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 3 residues within 4Å: Chain A: T.18, T.36 Ligands: GCP.2 4 PLIP interactions: 2 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:T.18, A:T.36, H2O.7, H2O.8 MG.5: 3 residues within 4Å: Chain C: T.18, T.36 Ligands: GCP.6 4 PLIP interactions: 2 interactions with chain C, 2 Ligand-Water interactions Metal complexes: C:T.18, C:T.36, H2O.16, H2O.18

2 x GCP: PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER(Non-covalent)

GCP.2: 22 residues within 4Å: Chain A: D.12, G.13, A.14, V.15, G.16, K.17, T.18, C.19, F.29, Y.33, P.35, T.36, A.60, G.61, K.117, D.119, L.120, S.159, A.160, L.161 Chain D: A.18 Ligands: MG.1 24 PLIP interactions: 24 interactions with chain A Hydrogen bonds: A:A.14, A:V.15, A:G.16, A:K.17, A:K.17, A:T.18, A:T.18, A:C.19, A:T.36, A:G.61, A:K.117, A:K.117, A:A.160, A:L.161 Water bridges: A:T.18, A:L.20, A:G.31, A:E.32, A:T.36, A:T.36, A:T.36, A:Q.62 Salt bridges: A:D.119 pi-Stacking: A:F.29 GCP.6: 22 residues within 4Å: Chain B: A.18 Chain C: D.12, G.13, A.14, V.15, G.16, K.17, T.18, C.19, F.29, Y.33, P.35, T.36, A.60, G.61, K.117, D.119, L.120, S.159, A.160, L.161 Ligands: MG.5 23 PLIP interactions: 23 interactions with chain C Hydrogen bonds: C:A.14, C:V.15, C:G.16, C:K.17, C:K.17, C:T.18, C:C.19, C:T.36, C:T.36, C:G.61, C:K.117, C:K.117, C:A.160, C:L.161 Water bridges: C:T.18, C:T.18, C:L.20, C:G.31, C:E.32, C:T.36, C:Q.62 Salt bridges: C:D.119 pi-Stacking: C:F.29

4 x GOL: GLYCEROL(Non-functional Binders)

GOL.3: 5 residues within 4Å: Chain A: K.167, D.171, R.175 Chain B: E.1, I.2 7 PLIP interactions: 4 interactions with chain A, 3 interactions with chain B Hydrogen bonds: A:K.167, A:K.167, A:R.175, A:R.175, B:I.2 Water bridges: B:E.1, B:E.1 GOL.4: 5 residues within 4Å: Chain A: R.164, G.165, L.166, K.167, T.168 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:G.165, A:K.167, A:T.168, A:T.168 Water bridges: A:L.166 GOL.7: 5 residues within 4Å: Chain C: K.167, D.171, R.175 Chain D: E.1, I.2 5 PLIP interactions: 4 interactions with chain C, 1 interactions with chain D Hydrogen bonds: C:K.167, C:K.167, C:R.175, C:R.175, D:I.2 GOL.8: 5 residues within 4Å: Chain C: R.164, G.165, L.166, K.167, T.168 5 PLIP interactions: 5 interactions with chain C Hydrogen bonds: C:G.165, C:K.167, C:T.168, C:T.168 Water bridges: C:L.166

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ugochukwu, E. et al., The crystal structure of the human RAC3 in complex with the CRIB domain of human p21-activated kinase 1 (PAK1). To be Published

Release Date

2007-08-28

Peptides

Ras-related C3 botulinum toxin substrate 3: AC
CRIB domain of the Serine/threonine-protein kinase PAK 1: BD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

C
A

B
I

D
I

Ras-related C3 botulinum toxin substrate 3

CRIB domain of the Serine/threonine-protein kinase PAK 1

Related Entries With Identical Sequence